Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
- 1 August 1992
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 93 (2) , 181-186
- https://doi.org/10.1016/0002-9343(92)90049-h
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- What is the "true" antigen for anticardiolipin antibodies?The Lancet, 1991
- Antiphospholipid antibodies: more than just a disease marker?Immunology Today, 1990
- Anticardiolipin antibodies and binding of anionic phospholipids and serum proteinThe Lancet, 1990
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristicsBritish Journal of Haematology, 1989
- Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene columnBiochemical and Biophysical Research Communications, 1988
- Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-IBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980
- Über ein bisher unbekanntes niedermolekulares β2-Glubulin des HumanserumsThe Science of Nature, 1961